XML 12 R2.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Current assets:    
Cash $ 15,853 $ 10,653
Trade accounts receivable, net of allowance for doubtful accounts of $334 and $317, respectively 16,235 21,054
Inventories, net 28,179 28,193
Prepaid expenses and other current assets 4,271 4,596
Total current assets 64,538 64,496
Property, plant and equipment, net 23,035 22,850
Goodwill 26,998 27,018
Other intangible assets, net 8,725 9,209
Deferred income taxes, net 11,700 11,836
Other noncurrent assets 1,816 2,292
Total Assets 136,812 137,701
Current Liabilities:    
Accounts payable 9,206 10,839
Current portion of long-term debt 253 1,361
Accrued compensation and related benefits 1,153 1,748
Accrued expenses and other current liabilities 6,076 4,758
Total current liabilities 16,688 18,706
Deferred income taxes 475 515
Other noncurrent liabilities 1,103 1,557
Total liabilities 18,266 20,778
Commitments and contingencies (Note 8)
Stockholders' equity:    
Preferred stock – par value $.10 per share; authorized 1,000,000 shares; none issued 0 0
Common stock – par value $.10 per share; authorized 40,000,000 shares; issued – 20,513,344 shares at September 30, 2021 and 20,373,519 shares at December 31, 2020; outstanding – 16,080,749 shares at September 30, 2021 and 15,959,984 shares at December 31, 2020 2,051 2,037
Capital in excess of par value 186,360 185,464
Accumulated deficit (46,701) (47,598)
Accumulated other comprehensive loss (1,819) (1,782)
Treasury stock - at cost; 4,432,595 shares at September 30, 2021 and 4,413,535 shares at December 31, 2020 (21,469) (21,321)
Total Ultralife Corporation equity 118,422 116,800
Non-controlling interest 124 123
Total stockholders’ equity 118,546 116,923
Total liabilities and stockholders' equity $ 136,812 $ 137,701